{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:33:31Z","timestamp":1789929211458,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T00:00:00Z","timestamp":1395878400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-225","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T14:19:17Z","timestamp":1395929957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12\/SDF-1 expression in the metastatic niches"],"prefix":"10.1186","volume":"14","author":[{"given":"Lopamudra Das","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Sahraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L","family":"Schettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlia M","family":"Besmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinku","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"issue":"1","key":"4424_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322\/caac.20138.","journal-title":"CA Cancer J Clin"},{"key":"4424_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000092969","volume":"13","author":"KE de Visser","year":"2006","unstructured":"de Visser KE, Coussens LM: The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol. 2006, 13: 118-137.","journal-title":"Contrib Microbiol"},{"issue":"7050","key":"4424_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature. 2005, 436 (7050): 518-524. 10.1038\/nature03799.","journal-title":"Nature"},{"issue":"11","key":"4424_CR4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.amjmed.2007.04.005","volume":"120","author":"V Majithia","year":"2007","unstructured":"Majithia V, Geraci SA: Rheumatoid arthritis: diagnosis and management. Am J Med. 2007, 120 (11): 936-939. 10.1016\/j.amjmed.2007.04.005.","journal-title":"Am J Med"},{"issue":"8","key":"4424_CR5","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/rheumatology\/ker143","volume":"50","author":"J Ji","year":"2011","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J: Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford). 2011, 50 (8): 1513-1518. 10.1093\/rheumatology\/ker143. doi:10.1093\/rheumatology\/ker143. Epub 2011 Apr 15","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"4424_CR6","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2345","volume":"11","author":"L Das Roy","year":"2009","unstructured":"Das Roy L, Pathangey L, Tinder T, Schettini J, Gruber H, Mukherjee P: Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res. 2009, 11 (4): R56-10.1186\/bcr2345.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4424_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1471-2407-11-365","volume":"11","author":"L Das Roy","year":"2011","unstructured":"Das Roy L, Ghosh S, Pathangey LB, Tinder TL, Gruber HE, Mukherjee P: Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. BMC Cancer. 2011, 11 (1): 365-10.1186\/1471-2407-11-365.","journal-title":"BMC Cancer"},{"issue":"2","key":"4424_CR8","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/bcr3412","volume":"15","author":"LD Roy","year":"2013","unstructured":"Roy LD, Curry JM, Sahraei M, Besmer DM, Kidiyoor A, Gruber HE, Mukherjee P: Arthritis augments breast cancer metastasis: role of mast cells and SCF\/c-Kit signaling. Breast Cancer Res. 2013, 15 (2): R32-10.1186\/bcr3412.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"4424_CR9","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996, 183 (6): 2593-2603. 10.1084\/jem.183.6.2593.","journal-title":"J Exp Med"},{"key":"4424_CR10","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/bcr2195","volume":"10","author":"X Zhu","year":"2008","unstructured":"Zhu X, Mulcahy L, Mohammed R, Lee A, Franks H, Kilpatrick L, Yilmazer A, Paish E, Ellis I, Patel P, Jackson A: IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res. 2008, 10: R95-10.1186\/bcr2195.","journal-title":"Breast Cancer Res"},{"key":"4424_CR11","doi-asserted-by":"publisher","first-page":"491985","DOI":"10.1155\/2009\/491985","volume":"2009","author":"EL Hsu","year":"2009","unstructured":"Hsu EL, Chen N, Westbrook A, Wang F, Zhang R, Taylor RT, Hankinson O: Modulation of CXCR4, CXCL12, and tumor cell invasion potential in vitro by phytochemicals. J Oncol. 2009, 2009: 491985-","journal-title":"J Oncol"},{"issue":"2","key":"4424_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10585-008-9210-2","volume":"27","author":"CV Hinton","year":"2010","unstructured":"Hinton CV, Avraham S, Avraham HK: Role of the CXCR4\/CXCL12 signaling axis in breast cancer metastasis to the brain. Clin Exp Metastasis. 2010, 27 (2): 97-105. 10.1007\/s10585-008-9210-2.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"4424_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/leu.2008.299","volume":"23","author":"JA Burger","year":"2009","unstructured":"Burger JA, Peled A: CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia. 2009, 23 (1): 43-52. 10.1038\/leu.2008.299.","journal-title":"Leukemia"},{"key":"4424_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2407-8-228","volume":"8","author":"K Tao","year":"2008","unstructured":"Tao K, Fang M, Alroy J, Sahagian GG: Imagable 4\u00a0T1 model for the study of late stage breast cancer. BMC Cancer. 2008, 8: 228-10.1186\/1471-2407-8-228.","journal-title":"BMC Cancer"},{"issue":"5","key":"4424_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ymthe.2004.02.019","volume":"9","author":"M Nakamori","year":"2004","unstructured":"Nakamori M, Fu X, Rousseau R, Chen SY, Zhang X: Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity. Mol Ther. 2004, 9 (5): 658-665. 10.1016\/j.ymthe.2004.02.019.","journal-title":"Mol Ther"},{"issue":"3","key":"4424_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jgm.1005","volume":"9","author":"H Li","year":"2007","unstructured":"Li H, Dutuor A, Fu X, Zhang X: Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model. J Gene Med. 2007, 9 (3): 161-169. 10.1002\/jgm.1005.","journal-title":"J Gene Med"},{"key":"4424_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nature02119","volume":"426","author":"N Sakaguchi","year":"2003","unstructured":"Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S: Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003, 426: 454-460. 10.1038\/nature02119.","journal-title":"Nature"},{"key":"4424_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1084\/jem.20041758","volume":"201","author":"H Yoshitomi","year":"2005","unstructured":"Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T, Sakihama T, Hirota K, Tanaka S, Nomura T, Miki I, Gordon S, Akira S, Nakamura T, Sakaguchi S: A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med. 2005, 201: 949-960. 10.1084\/jem.20041758.","journal-title":"J Exp Med"},{"issue":"3","key":"4424_CR19","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1128\/MCB.12.3.954","volume":"12","author":"CT Guy","year":"1992","unstructured":"Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992, 12 (3): 954-961.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4424_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00002371-200301000-00006","volume":"26","author":"P Mukherjee","year":"2003","unstructured":"Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ: Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. J Immunother. 2003, 26 (1): 47-62. 10.1097\/00002371-200301000-00006.","journal-title":"J Immunother"},{"issue":"4","key":"4424_CR21","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.4049\/jimmunol.177.4.2391","volume":"177","author":"GD Basu","year":"2006","unstructured":"Basu GD, Tinder TL, Bradley JM, Tu T, Hattrup CL, Pockaj BA, Mukherjee P: Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. J Immunol. 2006, 177 (4): 2391-2402.","journal-title":"J Immunol"},{"key":"4424_CR22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1541-7786.632.2.11","volume":"2","author":"G Basu","year":"2004","unstructured":"Basu G, Pathangey L, Tinder T, LaGioia M, Gendler S, Mukherjee P: COX-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Mol Cancer Res. 2004, 2: 632-642.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"4424_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1046\/j.1365-2567.2003.01656.x","volume":"109","author":"D Chen","year":"2003","unstructured":"Chen D, Xia J, Tanaka Y, Chen H, Koido S, Wernet O, Mukherjee P, Gendler SJ, Kufe D, Gong J: Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology. 2003, 109 (2): 300-307. 10.1046\/j.1365-2567.2003.01656.x.","journal-title":"Immunology"},{"issue":"5","key":"4424_CR24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF: Collagen-induced arthritis. Nat Protoc. 2007, 2 (5): 1269-1275. 10.1038\/nprot.2007.173.","journal-title":"Nat Protoc"},{"issue":"Unit 15.5","key":"4424_CR25","first-page":"1","volume":"Chapter 15","author":"EF Rosloniec","year":"2010","unstructured":"Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD: Collagen-induced arthritis. Curr Protoc Immunol. 2010, Chapter 15 (Unit 15.5): 1-25. doi:10.1002\/0471142735.im1505s89; PMID:20376842","journal-title":"Curr Protoc Immunol"},{"issue":"12","key":"4424_CR26","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/onc.2010.526","volume":"30","author":"LD Roy","year":"2011","unstructured":"Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL, Bajaj E, Shanmugam K, Lee YY, Hwang SI, Gendler SJ, Mukherjee P: MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene. 2011, 30 (12): 1449-1459. 10.1038\/onc.2010.526.","journal-title":"Oncogene"},{"issue":"13","key":"4424_CR27","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1158\/0008-5472.CAN-10-4439","volume":"71","author":"DM Besmer","year":"2011","unstructured":"Besmer DM, Curry JM, Roy LD, Tinder TL, Sahraei M, Schettini J, Hwang SI, Lee YY, Gendler SJ, Mukherjee P: Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. Cancer Res. 2011, 71 (13): 4432-4442. 10.1158\/0008-5472.CAN-10-4439.","journal-title":"Cancer Res"},{"issue":"1","key":"4424_CR28","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.2349\/biij.2.1.e10","volume":"2","author":"M Woo","year":"2006","unstructured":"Woo M, Nordal R: Commissioning and evaluation of a new commercial small rodent x-ray irradiator. Biomed Imaging Interv J. 2006, 2 (1): e10-","journal-title":"Biomed Imaging Interv J"},{"issue":"9","key":"4424_CR29","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1158\/1078-0432.CCR-07-2223","volume":"14","author":"MB Meads","year":"2008","unstructured":"Meads MB, Hazlehurst LA, Dalton WS: The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008, 14 (9): 2519-2526. 10.1158\/1078-0432.CCR-07-2223.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4424_CR30","doi-asserted-by":"publisher","first-page":"C987","DOI":"10.1152\/ajpcell.00406.2006","volume":"292","author":"I Kryczek","year":"2007","unstructured":"Kryczek I, Wei S, Keller E, Liu R, Zou W: Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol. 2007, 292 (3): C987-C995.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"4424_CR31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.celrep.2013.11.001","volume":"5","author":"JD Holland","year":"2013","unstructured":"Holland JD, Gyorffy B, Vogel R, Eckert K, Valenti G, Fang L, Lohneis P, Elezkurtaj S, Ziebold U, Birchmeier W: Combined Wnt\/\u03b2-catenin, Met, and CXCL12\/CXCR4 signals characterize basal breast cancer and predict disease outcome. Cell Rep. 2013, 5 (5): 1214-27. 10.1016\/j.celrep.2013.11.001. doi:10.1016\/j.celrep.2013.11.001; PMID:24290754","journal-title":"Cell Rep"},{"issue":"11","key":"4424_CR32","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP: CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res. 2010, 16 (11): 2927-2931. 10.1158\/1078-0432.CCR-09-2329.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4424_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","volume":"28","author":"I Petit","year":"2007","unstructured":"Petit I, Jin D, Rafii S: The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007, 28 (7): 299-307. 10.1016\/j.it.2007.05.007.","journal-title":"Trends Immunol"},{"issue":"6824","key":"4424_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Ver\u00e1stegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410 (6824): 50-56. 10.1038\/35065016.","journal-title":"Nature"},{"issue":"1","key":"4424_CR35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","volume":"161","author":"M Chabaud","year":"1998","unstructured":"Chabaud M, Fossiez F, Taupin JL, Miossec P: Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 1998, 161 (1): 409-414.","journal-title":"J Immunol"},{"issue":"1","key":"4424_CR36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1189\/jlb.68.1.144","volume":"68","author":"IK Campbell","year":"2000","unstructured":"Campbell IK, Rich MJ, Bischof RJ, Hamilton JA: The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol. 2000, 68 (1): 144-150.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"4424_CR37","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999, 103 (9): 1345-1352. 10.1172\/JCI5703.","journal-title":"J Clin Invest"},{"issue":"2 Suppl 7","key":"4424_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.seminoncol.2004.03.042","volume":"31","author":"B Arun","year":"2004","unstructured":"Arun B, Goss P: The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol. 2004, 31 (2 Suppl 7): 22-29.","journal-title":"Semin Oncol"},{"key":"4424_CR39","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/jnci\/90.11.802","volume":"90","author":"J Ziegler","year":"1998","unstructured":"Ziegler J: Cancer and arthritis share underlying processes. J Natl Cancer Inst. 1998, 90: 802-803. 10.1093\/jnci\/90.11.802.","journal-title":"J Natl Cancer Inst"},{"key":"4424_CR40","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"L Coussens","year":"2002","unstructured":"Coussens L, Werb Z: Inflammation and cancer. Nature. 2002, 420: 860-867. 10.1038\/nature01322.","journal-title":"Nature"},{"key":"4424_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.semcancer.2004.06.006","volume":"14","author":"M Philip","year":"2004","unstructured":"Philip M, Rowley D, Schreiber H: Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004, 14: 433-439. 10.1016\/j.semcancer.2004.06.006.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4424_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995, 1 (1): 27-31. 10.1038\/nm0195-27.","journal-title":"Nat Med"},{"issue":"5","key":"4424_CR43","first-page":"792","volume":"35","author":"M Seki","year":"1995","unstructured":"Seki M, Uzuki M, Ohmoto H, Yoshino K, Maeda S, Kokubun S, Sakurai M, Sawai T: Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis. Ryumachi. 1995, 35 (5): 792-801.","journal-title":"Ryumachi"},{"issue":"5","key":"4424_CR44","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","volume":"164","author":"M Ziolkowska","year":"2000","unstructured":"Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W: High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 2000, 164 (5): 2832-2838.","journal-title":"J Immunol"},{"issue":"8","key":"4424_CR45","first-page":"890","volume":"1","author":"H Tilg","year":"1998","unstructured":"Tilg H, Kaser A: IL-6 and arthritis: a detrimental or beneficial mediator?. IDrugs. 1998, 1 (8): 890-895.","journal-title":"IDrugs"},{"key":"4424_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2005.07.006","volume":"16","author":"A Ben-Baruch","year":"2006","unstructured":"Ben-Baruch A: Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol. 2006, 16: 38-52. 10.1016\/j.semcancer.2005.07.006.","journal-title":"Semin Cancer Biol"},{"key":"4424_CR47","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1172\/JCI32533","volume":"117","author":"P Sansone","year":"2007","unstructured":"Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu K, Chieco P, Bonafe M: IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007, 117: 3988-4002. 10.1172\/JCI32533.","journal-title":"J Clin Invest"},{"key":"4424_CR48","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1158\/0008-5472.CAN-08-0206","volume":"68","author":"J Nam","year":"2008","unstructured":"Nam J, Terabe M, Kang M, Chae H, Voong N, Yang Y, Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky JA, Wakefield LM: Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res. 2008, 68: 3915-3923. 10.1158\/0008-5472.CAN-08-0206.","journal-title":"Cancer Res"},{"issue":"10","key":"4424_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrrheum.2009.179","volume":"5","author":"WB van den Berg","year":"2009","unstructured":"van den Berg WB, Miossec P: IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol. 2009, 5 (10): 549-553. 10.1038\/nrrheum.2009.179.","journal-title":"Nat Rev Rheumatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-225\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:21:12Z","timestamp":1689088872000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,27]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4424"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-225","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,27]]},"assertion":[{"value":"5 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"225"}}